The digital, fast and accurate method to detect COVID-19 antibodies.
RACORDIAX is a product of BacTrace BioTec AG
RACORDIAX
The digital, fast and accurate method to detect COVID-19 antibodies.
The RACORDIAX COVID-19 antibody rapid test was developed to simultaneously analyze the current status of IgM, IgG and IgA antibodies as quickly and accurately as possible via a digital platform.
Manufactured in Germany, the CE-marked test provides a test result with 99.41% sensitivity and 99.13% specificity in just 10 minutes, using the appropriate smartphone iOS or Android RACORDIAX App.
BacTrace BioTec AG works closely with a renowned and decorated Scientific Advisory Board as well as with internationally recognized universities and scientific institutions.
Prof. Dr. Dr. h.c. mult. Willi Jäger, Universität Heidelberg
Dipl.-Ing. Manfred Opel, Brigade General a.D.
Prof. Dr. Valentin N. Pavlov, Bashkir State Medical University
Priv.-Doz. Dr. med. Michael T. Pawlik, Universität Regensburg
Dr. med. Sören Wagner, Harvard Medical School
Prof. Dr. med. Dr. h.c. mult. Wolf F. Wieland, Universität Regensburg
Dr. med. Hans Hermann Wörl
Contact
BacTrace BioTec AG Autharistrasse 31 81545 Munich Germany